ABAlikhan Bilyalov

Alikhan Bilyalov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alikhan Bilyalov has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Colonic diseases: epidemiology, risk factors, diagnosis, and prevention (Global trends and data from Kazakhstan). A literature review

    by Nurymzhan Murzagulov, Zhansaya Telmanova, Bolat Abishev, Rustem Moldagali, Banurzhan Zhangalov, Svetlana Muratbekova, Kulsara Rustemova, Niyazbek Mamatov, Yuriy Lissitsyn, Asset Bektasov, et al.

    Relevance. Colorectal cancer, Crohn’s disease, ulcerative colitis, and colonic polyposis are major public health problems. These diseases reduce quality of life, increase disability and healthcare costs, and affect screening policy. Population aging, urbanization, and lifestyle changes have altered their incidence and age distribution in many countries. This burden makes their epidemiological assessment particularly important for public health planning, prevention, early detection, and organization of appropriate healthcare services. Objective. To summarize recent evidence on the epidemiology, risk factors, diagnosis, and prevention of major colon diseases worldwide and in Kazakhstan, with attention to regional differences and gaps in knowledge. Evidence was considered globally and nationally to provide comparative perspective. Methodology. A structured narrative literature review was conducted using PubMed, Scopus, eLibrary, and Google Scholar. The initial literature search was performed from June to August 2025, and the evidence base was subsequently updated to include relevant publications available through October 2026. The review primarily covered literature published between 2015 and 2026, with earlier landmark studies included where appropriate. Eligible sources comprised original research articles, systematic reviews, meta-analyses, clinical guidelines, authoritative reference materials, and official epidemiological and statistical reports. A total of 89 sources were included in the final narrative synthesis. Results. Colorectal cancer remains a major contributor to cancer incidence and mortality worldwide and in Kazakhstan. According to GLOBOCAN 2024 estimates, colorectal cancer accounted for 3,598 new cases (12.1% of all estimated cancer cases) in Kazakhstan. National statistical data demonstrated regional differences in colorectal cancer incidence and the continued occurrence of advanced-stage disease. Colorectal carcinogenesis involves chromosomal instability, microsatellite instability, and serrated neoplasia pathways, while hereditary syndromes contribute to increased individual risk. Advances in image-enhanced endoscopy, artificial intelligence-assisted colonoscopy, capsule endoscopy, and molecular testing offer additional diagnostic opportunities. However, gaps remain in population-based epidemiological data on inflammatory bowel diseases and colonic polyposis in Kazakhstan. Conclusions. The reviewed evidence highlights the importance of risk-factor modification, organized colorectal cancer screening, early detection and removal of precancerous lesions, and risk-adapted surveillance of individuals with hereditary predisposition. For Kazakhstan, priorities include improving screening quality, strengthening national cancer registration and epidemiological monitoring, expanding access to diagnostic services, and developing population-based research on inflammatory bowel diseases and colonic polyposis. Modern diagnostic technologies should complement established clinical pathways rather than replace colonoscopy and histological examination. Keywords: colorectal neoplasms, Crohn disease, ulcerative colitis, intestinal polyposis, epidemiology, Kazakhstan.

  • Open Access

    RECTAL CANCER IN KAZAKHSTAN, 2005–2024: COMPONENT ANALYSIS OF INCIDENCE TRENDS IN THE CONTEXT OF SCREENING AND COVID-19

    by N.S. Igissin, Zh.B. Telmanova, N.A. Murzagulov, G.S. Igissinova, D.K. Turebaev, S.S. Dyakov, R.S. Moldagali, I.YU. Shishkin, A.R. Bilyalov, N.N. Mamatov, et al.

    Introduction. Rectal cancer constitutes a sizable share of the oncology workload. Reliable interpretation of long‑term trends requires disentangling demographic forces from genuine changes in age‑specific risk, particularly during program roll‑out and the service disruptions associated with COVID‑19. The aim of the study is to quantify the separate contributions of population size, age structure, and age‑specific risk to rectal cancer incidence in Kazakhstan, 2005–2024, partitioned into five phases: pre‑screening (2005–2010), early roll‑out (2011–2013), program stabilization (2014–2019), pandemic impact (2020–2021), and post‑pandemic recovery (2022–2024). Material and research methods. A population‑based retrospective study using the Ministry of Health Form No. 7 (ICD‑10: C19–C21). We applied a seven‑term decomposition with demographic components and risk‑related terms; here, “risk” denotes residual change in age‑specific incidence after removing demographic effects. Results. Over 2005–2024, 28,368 new cases were registered. The crude incidence rate (CR) increased from 7.80 to 9.13 per 100,000 (+1.34). Decomposition of CR yielded: ∑ΔA=+1.42, ∑ΔR=−0.05, ∑ΔRA=−0.03 (per 100,000), indicating a rise driven by population ageing with stable or slightly declining age-specific risks. By phase: 2005–2010 – declines in CR and ASR due to ΔR0); 2014–2019 – CR rises while ASR falls, increase fully demographic; 2020–2021 – compensatory increase versus 2020, yet 2021 below 2019; 2022–2024 – CR rises with a “flat” ASR, contribution almost exclusively demographic. Age profile stable: ages 50–79 ≈80.7% of registrations. Conclusions. The upward drift in crude incidence is primarily demographic, while true risk variation is phase‑bound and program‑linked. Policy should prioritize resilient early‑detection pathways, surge capacity for endoscopy, and routine component‑based surveillance focused on ages 50–79. Введение. Рак прямой кишки вносит существенный вклад в суммарную нагрузку онкологических заболеваний. Корректная интерпретация временных рядов требует раздельной оценки демографических эффектов и подлинной динамики возраст‑специфического риска, особенно при развёртывании организованного скрининга и структурных ограничениях периода COVID‑19. Цель исследования: количественно разложить вклад демографических факторов (численность населения и возрастная структура) и возраст‑специфического риска в изменение заболеваемости раком прямой кишки в Казахстане в 2005-2024 гг., с анализом пяти фаз: доскрининговый этап (2005-2010), раннее развёртывание (2011-2013), стабилизация программы (2014-2019), пандемическое воздействие (2020-2021) и постпандемическое восстановление (2022-2024). Материалы и методы. Популяционное ретроспективное исследование на основе официальной отчётной формы № 7 Минздрава РК (МКБ‑10: C19–C21). Для оценки динамики числа случаев применено компонентное разложение с выделением семи факторов. Результаты. За 2005–2024 гг. зарегистрировано 28 368 первичных случаев. Грубый показатель заболеваемости (ГП) вырос с 7,80 до 9,13 на 100 000 (+1,34). Декомпозиция ГП: суммарно ∑ΔA=+1,42, ∑ΔR=−0,05, ∑ΔRA=−0,03 (на 100 000) – прирост обусловлен старением населения при стабильных/слегка снижающихся возрастных рисках. По этапам: 2005–2010 – снижение ГП и ВСП за счёт ΔR0); 2014–2019 – рост ГП при снижении ВСП, прирост полностью демографический; 2020–2021 – компенсаторный рост относительно 2020 г., но уровень 2021 г. ниже 2019 г.; 2022–2024 – рост ГП при «плоском» ВСП, вклад почти исключительно демографический. Возрастной вклад устойчив: 50–79 лет ≈80,7% всех регистраций. Выводы. Долгосрочный рост заболеваемости определяется главным образом старением и увеличением численности населения; изменения «истинного» риска носят кратковременный характер и совпадают с программными и организационными сдвигами. Рекомендуется внедрять устойчивое компонентное наблюдение, планировать резерв мощности эндоскопии и фокусировать профилактику на когортах 50–79 лет. Кіріспе. Тік ішек қатерлі ісігі онкологиялық қызметтің елеулі бөлігін құрайды. Ұзақ мерзімді динамиканы дұрыс түсіндіру үшін демографиялық әсерлерді жас‑ерекшелік...

  • Open Access

    Тренды заболеваемости раком предстательной железы в Казахстане: Результаты компонентного анализа

    by Н.с. Игісін, Н.е. Ермек, И.ю. Шишкин, Ж.б. Тельманова, Г.с. Игисинова, Д.к. Туребаев, Р.с. Молдагали, С.с. Дьяков, А.е. Нарбаев, Д.м. Байбосынов, et al.

    The aim of this study is to assess the dynamics of prostate cancer incidence in Kazakhstan during the period 2005–2019 using component analysis methods. A retrospective epidemiological study was conducted based on data from the National Cancer Registry of Kazakhstan. Statistical methods included the calculation of age-standardized incidence rates, analysis of average annual growth rates, and component analysis of factors contributing to the increase in incidence. A total of 14,740 new prostate cancer cases were registered during the study period. The agestandardized incidence rate was 17.0 per 100.000 male population, showing an upward trend (T=+5.6%). The main factors contributing to the increase in incidence were changes in the age structure of the population (+10.9%), growthin the male population (+23.1%), and an increased risk of developing prostate cancer (+57.0%). The rising incidence of prostate cancer in Kazakhstan aligns with global trends and may be attributed to improved diagnostics, population aging, and changing risk factors. The findings can inform the development of prevention strategies, optimization of screening programs, and improvement of oncological care in the country.